Announced
Synopsis
IQVIA, a provider of advanced analytics, technology solutions, and clinical research services, agreed to acquire the remaining 40% stake in Q2 Solutions, a clinical trial laboratory services, from Quest Diagnostics, a provider of diagnostic information services, for $760m. "We are proud of our contributions to the growth of Q2 Solutions, and are confident that IQVIA has the strategic vision and agility to lead Q2 Solutions on the next phase of its journey as a global leader in central lab services," Steve Rusckowski, Quest Diagnostics Chairman, CEO and President.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.